Oticon Pink Delta Hearing Device Helps Raise Breast Cancer Awareness And Funds

Somerset, NJ - It is a fact that some people undergoing chemotherapy may experience the effects of ototoxicity, a condition in which platinum-based chemotherapy drugs damage the tiny hair cells in the inner ear that vibrate in response to sound waves¹. The result is often high frequency hearing loss.

That's why the new Think Pink hearing device, just introduced by leading hearing device manufacturer Oticon, Inc., may have special significance for hearing aid users and especially for those who are breast cancer survivors.

Oticon Delta "Think Pink" is a sleek, trendy and distinctively pink hearing device that allows wearers to promote breast cancer awareness and help raise funds for breast cancer research. During October, National Breast Cancer Awareness Month, Oticon Inc. will donate a portion of proceeds from the sale of each Delta "Think Pink" and all other Delta hearing devices to the American Cancer Society to support breast cancer research.

"Delta's outstanding sound quality and design have been award-winners around the world," says Peer Lauritsen, President of Oticon, Inc. "With Delta ‘Think Pink,' we offer people with hearing loss a wonderful way to raise consciousness of a disease that affects so many women and to pay tribute to those who have battled breast cancer."

The sleek, triangular hearing instrument is discrete, light and comfortable. It combines great-looking, contemporary design with state-of-the-art digital technology to meet important image and style demands while giving users the boost in speech clarity that they need.

For more information about hearing loss or the new Delta "Think Pink" visit oticonusa.com.

¹Study by the Oregon Health & Science University, reported in the Journal of Clinical Oncology, 12/2005.

SOURCE: Oticon, Inc.